Aubagio (Genzyme Corp.)
Welcome to the PulseAid listing for the Aubagio drug offered from Genzyme Corp.. This Pyrimidine Synthesis Inhibitor [EPC],Dihydroorotate Dehydrogenase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genzyme Corp. |
NON-PROPRIETARY NAME: | teriflunomide |
SUBSTANCE NAME: | TERIFLUNOMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Pyrimidine Synthesis Inhibitor [EPC],Dihydroorotate Dehydrogenase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-05-01 |
END MARKETING DATE: | 2054-12-31 |
Aubagio HUMAN PRESCRIPTION DRUG Details:
Item Description | Aubagio from Genzyme Corp. |
LABELER NAME: | Genzyme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 14(mg/1) |
START MARKETING DATE: | 2013-05-01 |
END MARKETING DATE: | 2054-12-31 |
PRODUCT ID: | 58468-0210_7c6d1678-6f96-4b89-b130-2616db908d68 |
PRODUCT NDC: | 58468-0210 |
APPLICATION NUMBER: | NDA202992 |
Other TERIFLUNOMIDE Pharmaceutical Manufacturers / Labelers: